GRFSGrifols, SA
Mkt Cap
$6.99BVolume
303,346.0052W High
$11.1452W Low
$6.19PE Ratio
19.58GRFS Fundamentals
Price
$9.24Prev Close
$9.39Open
$9.3350D MA
$9.75Beta
0.90Avg. Volume
526,187.19EPS (Annual)
$0.2495P/B
1.05Rev/Employee
$327,343.05Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma Segment includes all activities related with products deriving from human plasma for therapeutic use. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols i Roig in 1909 and is headquartered in Barcelona, Spain.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
23,833
Frequently Asked Questions
What is Market Cap of Grifols SA - ADR - Level III?
What is the 52-week high for Grifols SA - ADR - Level III?
What is the 52-week low for Grifols SA - ADR - Level III?
What is Grifols SA - ADR - Level III stock price today?
What was Grifols SA - ADR - Level III stock price yesterday?
What is the PE ratio of Grifols SA - ADR - Level III?
What is the Price-to-Book ratio of Grifols SA - ADR - Level III?
What is the 50-day moving average of Grifols SA - ADR - Level III?
How many employess does Grifols SA - ADR - Level III has?